US FDA approves Mesoblast cell therapy for graft-versus-host disease By Reuters
(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Mesoblast's (NASDAQ:) cell therapy to treat a type of ...
(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Mesoblast's (NASDAQ:) cell therapy to treat a type of ...
(Reuters) - The U.S. Food and Drug Administration has approved Zevra Therapeutics' drug for a rare and fatal genetic disorder, ...
(Image credit: future)Frontline School Health Management is a single solution for school nurses, school counselors, social workers, administrators, and other ...
This is a guest post co-authored by Ajay K Gupta, Jean Felipe Teotonio and Paul A Churchyard from HSR.health. HSR.health ...
Since Taproot Wizard's infamous 4MB block, bitcoiners have been on fire, scrambling to try and stop signups. Registrations are definitely ...
Ehsan Vaghefi, CEO and co-founder of Minegrew up with a blind father who lost his sight at the age of ...
IvelinRadkov/iStock via Getty Images A national policy that limited the use of a type of brain scan called positron emission ...
On a muggy evening in July on the island of Príncipe, part of a volcanic archipelago 200 miles off the ...
JHVEPhoto Sanofi (NASDAQ:SNY) and Regeneron Pharmaceuticals' (NASDAQ: REGION) Dupixent met the primary endpoint and all key secondary endpoints of a ...